Well done on postings so far, some interesting and critical relfections on screening
Looking across your posts raised two questions:
Firstly, does screening for risk change what it means to be a patient?
While much screening (e.g. PKU) involves identfying a disease, there is a drive to screen for risk of disease (e.g. PSA). If you're identified as being 'at risk' does this mean that you are a patient or not? What does being 'a patient' now mean?
Secondly, and related to this, what are the implications for diagnosis and clinical care?
Might clinical diagnosis now include 'being at risk'? What does this mean for clinicians providing treatment and care?